Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status.
- Published in:
- PharmacoEconomics, 2015, v. 33, n. 7, p. 707, doi. 10.1007/s40273-014-0230-2
- By:
- Publication type:
- Article
Works matching IS 11707690 AND DT 2015 AND VI 33 AND IP 7
Results: 13
1
2
Do Statins Reduce the Health and Health Care Costs of Obesity?
- Published in:
- PharmacoEconomics, 2015, v. 33, n. 7, p. 723, doi. 10.1007/s40273-014-0234-y
- By:
- Publication type:
- Article
3
Obesity in the Context of Aging: Quality of Life Considerations.
- Published in:
- PharmacoEconomics, 2015, v. 33, n. 7, p. 655, doi. 10.1007/s40273-014-0237-8
- By:
- Publication type:
- Article
4
The Expected Net Present Value of Developing Weight Management Drugs in the Context of Drug Safety Litigation.
- Published in:
- PharmacoEconomics, 2015, v. 33, n. 7, p. 749, doi. 10.1007/s40273-015-0300-0
- By:
- Publication type:
- Article
5
The Economic Burden of Obesity by Glycemic Stage in the United States.
- Published in:
- PharmacoEconomics, 2015, v. 33, n. 7, p. 735, doi. 10.1007/s40273-014-0248-5
- By:
- Publication type:
- Article
6
The Challenges and Opportunities Associated with Reimbursement for Obesity Pharmacotherapy in the USA.
- Published in:
- PharmacoEconomics, 2015, v. 33, n. 7, p. 643, doi. 10.1007/s40273-015-0264-0
- By:
- Publication type:
- Article
7
The Effect of Obesity and Chronic Conditions on Medicare Spending, 1987-2011.
- Published in:
- PharmacoEconomics, 2015, v. 33, n. 7, p. 691, doi. 10.1007/s40273-015-0284-9
- By:
- Publication type:
- Article
8
Policy Makers' Views of Obesity-Related Challenges Around the World.
- Published in:
- PharmacoEconomics, 2015, v. 33, n. 7, p. 619, doi. 10.1007/s40273-015-0290-y
- By:
- Publication type:
- Article
9
The Epidemiology of Obesity: A Big Picture.
- Published in:
- PharmacoEconomics, 2015, v. 33, n. 7, p. 673, doi. 10.1007/s40273-014-0243-x
- By:
- Publication type:
- Article
10
Preventing Obesity in the USA: Impact on Health Service Utilization and Costs.
- Published in:
- PharmacoEconomics, 2015, v. 33, n. 7, p. 765, doi. 10.1007/s40273-015-0301-z
- By:
- Publication type:
- Article
11
Gap Between Evidence and Patient Access: Policy Implications for Bariatric and Metabolic Surgery in the Treatment of Obesity and its Complications.
- Published in:
- PharmacoEconomics, 2015, v. 33, n. 7, p. 629, doi. 10.1007/s40273-015-0302-y
- By:
- Publication type:
- Article
12
For a Step Change to Curb the Obesity Epidemic.
- Published in:
- PharmacoEconomics, 2015, v. 33, n. 7, p. 613, doi. 10.1007/s40273-015-0303-x
- By:
- Publication type:
- Article
13
Cost-Effectiveness Analysis of Qsymia for Weight Loss.
- Published in:
- PharmacoEconomics, 2015, v. 33, n. 7, p. 699, doi. 10.1007/s40273-014-0182-6
- By:
- Publication type:
- Article